1. Introduction {#s0005}
===============

Aging and disease, which affect the bony changes such as osteoporosis ([@b0040]), result in continued aggravation or alteration in bony quality and structure ([@b0060]). Osteoporosis, is a multifactorial skeletal disease characterized by a decrease in bone mass and disruption of bone microarchitecture, resulting in decreased bone strength and thus an increased risk of fracture ([@b0070]). The most studies have focused on bone mass as the important evidence in finding the cause of disease and understanding the trabecular bone and its structure ([@b0095]). The large changes observed in the biomechanical characteristics of trabecular bone should reveal the structural properties in the analysis ([@b0020]). Before, determination of bone strength depended on the bone mineral density. 94% of the mechanical properties of trabecular bone can be showed using a combination of bone density and architectural measurements but 64% with bone density measurement alone ([@b0050]). Therefore, more consideration could be given in measuring the trabecular microstructure with bone mass measurements. The trabecular bone has plates, rods, and combination of these in their microstructure. Three-dimensional CT has been introduced that make high-resolution images *in vivo* ([@b0115]). And it is sufficient to visualize the bone quality and trabecular bone structure ([@b0100]). Lately, traditional herbal medicines using natural ingredients have acquired considerable attention as possible treatments for osteoporosis with fewer side effects ([@b0105]).

*P. ginseng* has a variety of potential effects, including immune effects, anticancer effects, sexual function-enhancing effects, and others. However, few studies have assessed its anti-osteoporosis effects ([@b0080]). Many researchers have studied the anti-osteoporosis effects of *P. ginseng* in ovariectomized rats ([@b0035]). In the present study, we conducted histomorphometric analyses of the old rat tibia using microCT scans and evaluated changes in trabecular bone after *P. ginseng* treatment. In the aspect of osteoporosis, *Panaxnoto ginseng* saponins have been studied for their effects on pathological bone remodeling ([@b0120]). A ginseng mixture was reported to induce the deposition of bone mineral density (BMD), increase femoral trabecular width and estrogen levels, and decrease tartrate-resistant acid phosphatase (TRAP) activity in ovariectomized rats. However, ginseng extract has not been sufficiently studied in age-related osteoporosis. Therefore, we attempted to characterize the effects of ginseng in age-related osteoporosis by measuring the histologic structure, as part of an ongoing effort to provide scientific data on the effects of *P. ginseng.* MicroCT was introduced by Feldkamp in the 1980s ([@b0045]). It is highly accurate, non-destructive method that enables to produce a three dimensional image, where a larger number of slices and immediate analysis of small-sized calcified specimens in achievable (8). It is now frequently used for quantitative evaluation of the morphology and microarchitecture of trabecular bone in animal models ([@b0090]). Therefore, the purposes of this study are to measure the trabecular microstructure of tibia using micro-CT and to provide fundamental basis for more accurate biomechanical analysis such as micro-finite element analysis of the tibia.

2. Materials and methods {#s0010}
========================

2.1. Preparation of *P. Ginseng* extract {#s0015}
----------------------------------------

Four-year-old ground roots of *P. ginseng* were purchased from the Korea Medicine Herbal Association in Seoul. The plants were identified by the Institute of Rural Development Administration, where the voucher specimens were deposited. *P. ginseng* roots were extracted with water at 80--85 °C, and concentrated through a vacuum evaporator. Then, it was dried using a freeze dryer to prepare *P. ginseng* extract.

2.2. Biochemical analysis {#s0020}
-------------------------

The serum sample were prepared by centrifugation of the blood (1.013 g for 15 min 4 °C), then stored at then stored at −80 °C for biochemical assay. The serum osteocalcin (OC) concentration was determined using a rat OC ELISA kit (San Clemente, CA, USA). The levels of serum calcium was measured on an automatic analyzer (Ciba-Corning 550, USA) using a diagnostic reagent kit for the in vitro determination.

2.3. Experimental animal {#s0025}
------------------------

Male WISTAR rats were used in this experiment (ten were 8-week-old rats, ten were 112-week-old rats treated with vehicle, and ten were 112-week-old rats treated with *P. ginseng* at a daily dosage of 300 mg/kg body weight for 8 weeks). The rats were provided a standard pelleted diet and water *ad libitum*. The experimental animals were housed in an air-conditioned room at 23 °C ± 2 °C with 12 h/12 h light--dark illumination cycles at constant humidity (45--50%). The rats were housed in the Regional Innovation Center experimental animal facility at Kyung Hee University in accordance to the Institutional Animal Care and Use Committee guidelines. The appropriate amount of *P. ginseng* was determined and adjusted by weighing the rats weekly and measuring their daily dietary intake. The tibias were removed, fixed in 4% formaldehyde in phosphate-buffered saline (pH 7.4) for 24 h, and then stored (4 °C) in 80% ethanol for bone mass measurements.

2.4. MicroCT (micro-CT) imaging and histomorphometric analysis {#s0030}
--------------------------------------------------------------

micro-CT is an alternate approach to image and quantify trabecular bone in three dimensions. The previously reported methods was modified ([@b0130]). Each specimen was scanned and reconstructed into a three-dimensional structure with microCT (SkyScan 1172TM; SkyScan, Kontich, Belgium) with X-ray energy settings of 60 kV and 167 μA12. A two-dimensional X-ray CCD camera was connected to the frame-grabber and a dual Pentium III computer with CT-Analyzer software (SkyScan, Kontich, Belgium). For bone analysis, the tibia was selected as the region of interest. Bone volume (BV) is calculated by the marching cubes method to triangulate the surface of the trabecular bone 7. Total volume (TV) ix the volume of the whole examined sample and the normalized index, bone volume fraction (BV/TV) enables the comparison of samples of different size. The mean thickness of the trabecular, trabecular thickness (Tb, Th), is obtained by filling maximum size of spheres in the structure with the distance transformation ([@b0055]). Then the average thickness of al bone voxels is calculated to give Tb.Th. Trabecular separation (Tb.Sp) is the mean thickness of the marrow cavity. This value is calculated by using same method as the Tb. Th but the spheres are filled into non-bony part. Tb. Sp is thus the thickness of the marrow cavities. Trabecular number (Tb. N) is defined as the number of trabecular bone per unit length and taken as the inverse of the mean distance between the midaxes of the structure. Then the mean distance between the mid axes is determined in analogy to the Tb.Sp calculation, i.e., the separation between the midaxes is assessed ([@b0030]). Structural Model Index (SMI), an estimation of the plate-rod like characteristic of the structure is calculated by a differential analysis of a triangulated surface of the structure and is defined as SMI = 6{(BV(dBS/dr))/BS^2^}. The dBS/dr is the surface area derivative with respect to al linear measure r, corresponding to the half thickness or the radius assumed constant over the entire structure. The SMI values of 0 and 3 are an ideal plate and rod value, respectively. If both the rod and plate thickness are existed in a structure, the SMI values can vary between 0 and 3. All DEXA measurements were performed with the Norland pDEXA Sabre (Fort Atkinson, WI, USA) equipped with Sabre Research software (v3.6). Right tibias were scanned with DEXA to determine BMC and BMD. Ex vivo measurements of the right proximaltibias were performed on excised bones (1-mm-thick) on a 3-mm-thick piece of cotton in a 10 cm diameter culture dish at a constant location on the scan table.

2.5. Statistical analysis {#s0035}
-------------------------

Statistical analysis was performed by one-way analysis of variance (ANOVA) followed by Student's *t*-test. Results are expressed as means ± standard deviations (SD). A*p* value of \<0.05 was considered to indicate statistical significance.

3. Results and discussion {#s0040}
=========================

In this study, we successfully correlated imaging and histological analyses of the trabecular bone relationship in the aging skeleton. This study is the first to show the beneficial effects of *P. ginseng* on the decreases in bone mass and strength induced by aging and its ability to improve the cancellous bone structure in aging rats. Our findings show that at a concentration of 300 mg/kg, *P. ginseng* attenuates bone loss in aging rats. The mechanical characteristics of bone are influenced by bone mass as well as bone size, bone quality, and cancellous bone architecture ([@b0075]).

3.1. Biochemical parameters of serum {#s0045}
------------------------------------

Plasma osteocalcin activity, bone formation markers, was significantly increased in *P. ginseng* treated group compared with young rats group ([@b0110], [@b0125]). In this study, compared with old rats group, 8 weeks of treatment with 300 mg/kg *P. ginseng* significantly increased in serum osteocalcin level (p \< 0.01); *P. ginseng* at 300 mg/kg significantly increased serum calcium level (p \< 0.01) ([Fig. 1](#f0005){ref-type="fig"}). As osteocalcin is produced by osteoblasts ([@b0085]), it is often used as a marker for the bone formation process. It has been observed that higher serum-osteocalcin levels are relatively well correlated with increases in bone mineral density (BMD) during treatment with anabolic bone formation drugs ([@b0015]). And acts on Leydig cells of the testis to stimulate testosterone biosynthesis and therefore affect male fertility ([@b0065]).Fig. 1Effects of 8-week treatment with ginseng on biochemical parameters in serum osteocalcin and calcium of old rats. Values are means ± SD (n = 17). osteocalcin, serum calcium, compared with the Cont-O group ^\*\*^*P* \< 0.01 compared with the Cont-O group. Cont-Y: 8-week-young rats, Cont-O: 112-week-old rats, Ginseng: 112-week-old rats treated with *P. ginseng*.

3.2. Total bone and density of the tibia {#s0050}
----------------------------------------

Osteoporosis is a bone disease characterized by mass density reduction and a deterioration of the trabecular bone micro architecture thus increasing the risk of fracture is not sufficiently comprehensive for complete characterization of trabecular bone deterioration ([@b0030]).

BMD measurement is widely used for detecting osteoporosis. Bone mineral components, such as Ca, decreased in the tibia of the aging rats, indicating that Ca deposition decreased in aging rats. *P. ginseng* treatment also improved the loss of Ca content in aging rats. These factors indicated that *P. ginseng* not only inhibited bone resorption, but also increased the mineral concentration in the bones of aging rats. In the present study, bone loss was manifested by reductions in the tibial BMC and BMD in aging rats. Treatment with *P. ginseng* significantly reduced this bone loss in the aging rats. Although low bone mass is a major risk factor for fracture (borah) the preservation of trabecular bone architecture significantly contributes to bone strength and may reduce fracture risk beyond.

3.3. Trabecular microstructural changes in the proximal tibial metaphysis {#s0055}
-------------------------------------------------------------------------

[Table 1](#t0005){ref-type="table"} shows that old rats induced significant changes in all trabecular microstructural parameters in the proximal tibial metaphysis, as measured by micro-CT. Micro-CT revealed that proximal tibialmetaphysis from old rats had lower trabecular bone compared to *P. ginseng* treated group. The most relevant morphologic values in the characterization of trabecular bone are bone volume to total volume ratio, trabecular thickness, number and separation ([@b0005]). In addition, an evaluation of the bone strength helps in the characterization of some bone properties ([@b0040], [@b0010]). The basic morphometric indices include bone volume (BV) and the total volume of interest (TV). The ratio of these two measurements is termed the bone volume fraction (BV/TV). The 112-week-old rats treated with *P. ginseng* showed a significant 33% increase in BMD and a significant 45% increase in the trabecular BV/TV (18.78% ± 1.04% *vs.* 13.68% ± 0.33%, respectively). In addition, the 112-week-old rats showed a significant decrease in Tb.N. (0.22 ± 0.03/mm^2^*vs.* 0.33 ± 0.01/mm^2^, respectively) and a significant increase in Tb.Sp. (2.20 ± 0.18 mm *vs.* 1.59 ± 0.02 mm, respectively)compared with the 112-week-old rats treated with *P. ginseng*. Tb. Th. in the 112-week-old rats was slightly different from that in the 112-week-old rats treated *P. ginseng* (0.63 ± 0.06 in the 112-week-old rats and 0.59 ± 0.63 in the 112-week-old rats treated with *P. ginseng*). An SMI of 0 and 3 indicate bones that consist purely of plate or rod-like structures, respectively. *P. ginseng* treatment prevented the increase in SMI induced by aging ([Table 1](#t0005){ref-type="table"} and [Fig. 2](#f0010){ref-type="fig"}). MicroCT is an ideal strategy for tracking bone change and provides high resolution while allowing for longitudinal research of bone morphology. The microCT images of the tibia with the region of interest shown in white were reconstructed in three dimensions to see the structural details of the trabecular bone. Loss of trabecular bone was apparent in the 112-week-old rats compared with the 8-week-old rats, with associated signs of other changes in trabecular bone microarchitecture. The 112-week-old rats had fewer trabecular bone structures than did the 112-week-old rats treated with *P. ginseng* ([Fig. 2](#f0010){ref-type="fig"}). In the 112-week-old rats, the plate-like structures mostly resolved into rod-like structures with many missing connecting rods, whereas in the 112-week-old rats treated with *P. ginseng*, this loss of trabecular bone mass and connectivity was prevented ([Fig. 2](#f0010){ref-type="fig"}). BMD measurement is widely used for detecting osteoporosis. In the present study, bone loss was manifested by reductions in the tibial BMD in age related rats. Trabecular BMD was increased by 33% in *P. ginseng* treated group. BMD, suggesting that it can prevent the loss of bone mass associated with aging ([Table 2](#t0010){ref-type="table"}). One of the structural parameters, BMD analysis was conducted on samples formed by both cortical and cancellous bone, whereas microCT analysis was only performed on cancellous bone in this study. The results suggest that *P. ginseng* might increase bone strength by increasing BMD and trabecular architecture. Through this study, it was found that a relatively low dose of *P. ginseng* (300 mg/kg) showed higher efficacy preventing bone loss.Table 1Microstructural properties of the distal tibia by microCT analysis.Cont-YCont-O*P. ginseng*BV/TV (%)17.56 ± 3.4113.68 ± 0.3318.78 ± 1.04[b](#tblfn2){ref-type="table-fn"}Tb.N (/mm)0.29 ± 0.050.22 ± 0.030.33 ± 0.01[b](#tblfn2){ref-type="table-fn"}Tb.Th (mm)0.61 ± 0.010.63 ± 0.060.59 ± 0.03Tb.Sp (mm)1.84 ± 0.222.20 ± 0.18[a](#tblfn1){ref-type="table-fn"}1.59 ± 0.02[b](#tblfn2){ref-type="table-fn"}SMI2.83 ± 0.551.93 ± 0.842.19 ± 0.64[^1][^2][^3][^4]Fig. 2Three approaches to identifying the trabecular bone region of interest.Table 2BMD of the distal tibial trabecular bone.Cont-YCont-O*P. ginseng*BMD (mg/cm^3^)440.57 ± 76.39351.84 ± 40.19466.31 ± 29.62[a](#tblfn3){ref-type="table-fn"}[^5][^6][^7]

This study was originally aimed at documenting the antiosteoporosis effect of *P. ginseng.* However, our study has some limitations. The one is the presence of a well-formed and active growth plate affected the action of *P. ginseng* on bone. Another limitation is that the experiment was not performed using a different dose for the prevention of osteoporosis, more specific doses of ginseng especially doses lower than 300 mg/kg (100, 200 mg/kg) by micro CT.

4. Conclusion {#s0060}
=============

In summary, this study provides evidence that daily oral administration of *P. ginseng* contributes significantly to the prevention or treatment of the bone loss and deterioration of trabecular microarchitecture induced by aging in rats. Further studies are required to determine whether a dose higher than 300 mg/kg would provide better protection to bone microarchitecture. We believe that *P. ginseng* has potential for further development as a natural alternative for the management of senile osteoporosis.
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[^1]: Values are expressed at mean ± SD.

[^2]: Cont-Y: control 8-week-y rats, Cont-O: control 112-week-old rats, Ginseng: 112-week-old rats treated with *P. ginseng*, BV/TV: ratio of segmented bone volume to total volume of the region of interest, Tb.N: measure of the average trabecular number, Tb.Th: mean trabecular thickness assessed using direct 3D methods, Tb.Sp: mean trabecular distance assessed using direct 3D methods, SMI: structure model index, an indicator of the trabecular structure; SMI will be 0 for parallel plates and 3 for cylindrical rods.

[^3]: *p* \< 0.05 *vs.* Cont-Y group.

[^4]: *p* \< 0.05 *vs.* Cont-O.

[^5]: Values are expressed as mean ± SD.

[^6]: Cont-Y: 8-week-young rats, Cont-O: 112-week-old rats, Ginseng: 112-week-old rats treated with *P. ginseng*.

[^7]: *p* \< 0.05 *vs.* Cont-O.
